Kaiser Permanente EMR Integration Goes Live
15th November 2023
Pacific Edge announces the launch of the integration of Cxbladder tests within the Electronic Medical Records (EMR) system of Kaiser Permanente. Read More
Published economic model demonstrates significant savings for healthcare payers
08th November 2023
A budget impact model showing routine use of Cxbladder Detect delivers significant savings in the evaluation and treatment of hematuria patients is now published in Urology Practice. Read More
Cxbladder Bulletin - October 2023
25th October 2023
Pacific Edge invites you to read the October 2023 edition of the Cxbladder Bulletin. Read More
US Urological Societies Call for Medicare LCD Revision
29th August 2023
Pacific Edge welcomes the strong industry and clinician support it has received during the open public meetings to take feedback on draft local coverage determinations (LCDs) that propose non-coverage of Cxbladder tests by Medicare, the US national health insurance provider. Read More
Pacific Edge Provides Update on Kaiser EMR Integration
31st March 2023
Pacific Edge today announces it has completed the software development and integration testing on its project to integrate Cxbladder into the Electronic Medical Records (EMR) system of Kaiser Permanente. Read More
Study Adds Support for Cxbladder Monitor Use in Cancer Surveillance
13th March 2023
Pacific Edge today welcomes the release of new research supporting the clinical utility of the company’s genomic biomarker test Cxbladder Monitor in the surveillance for bladder cancer recurrence. Read More
Pacific Edge to Showcase Leading Biomarker Strategies for the Evaluation and Management of Bladder Cancer at SESAUA
08th March 2023
Pacific Edge today announces its key activities and highlights at the 87th Annual AUA Southeastern Section (SESAUA) meeting to be held March 15-18 in Amelia Island, Florida. Read More
Te Whatu Ora - Southern Commercial Agreement Completed
13th January 2023
Pacific Edge can now confirm a signed executed agreement has been received from Te Whatu Ora - Southern for the use of its non-invasive Cxbladder genomic biomarker tests. Read More